175 related articles for article (PubMed ID: 23300717)
1. C-terminal helical domains of dengue virus type 4 E protein affect the expression/stability of prM protein and conformation of prM and E proteins.
Tsai WY; Hsieh SC; Lai CY; Lin HE; Nerurkar VR; Wang WK
PLoS One; 2012; 7(12):e52600. PubMed ID: 23300717
[TBL] [Abstract][Full Text] [Related]
2. Characterization of the ectodomain of the envelope protein of dengue virus type 4: expression, membrane association, secretion and particle formation in the absence of precursor membrane protein.
Hsieh SC; Tsai WY; Nerurkar VR; Wang WK
PLoS One; 2014; 9(6):e100641. PubMed ID: 24950216
[TBL] [Abstract][Full Text] [Related]
3. The helical domains of the stem region of dengue virus envelope protein are involved in both virus assembly and entry.
Lin SR; Zou G; Hsieh SC; Qing M; Tsai WY; Shi PY; Wang WK
J Virol; 2011 May; 85(10):5159-71. PubMed ID: 21367896
[TBL] [Abstract][Full Text] [Related]
4. Antibodies against the envelope glycoprotein promote infectivity of immature dengue virus serotype 2.
da Silva Voorham JM; Rodenhuis-Zybert IA; Ayala Nuñez NV; Colpitts TM; van der Ende-Metselaar H; Fikrig E; Diamond MS; Wilschut J; Smit JM
PLoS One; 2012; 7(3):e29957. PubMed ID: 22431958
[TBL] [Abstract][Full Text] [Related]
5. Novel anti-dengue monoclonal antibody recognizing conformational structure of the prM-E heterodimeric complex of dengue virus.
Puttikhunt C; Keelapang P; Khemnu N; Sittisombut N; Kasinrerk W; Malasit P
J Med Virol; 2008 Jan; 80(1):125-33. PubMed ID: 18041028
[TBL] [Abstract][Full Text] [Related]
6. Generation and preclinical evaluation of a DENV-1/2 prM+E chimeric live attenuated vaccine candidate with enhanced prM cleavage.
Keelapang P; Nitatpattana N; Suphatrakul A; Punyahathaikul S; Sriburi R; Pulmanausahakul R; Pichyangkul S; Malasit P; Yoksan S; Sittisombut N
Vaccine; 2013 Oct; 31(44):5134-40. PubMed ID: 23973247
[TBL] [Abstract][Full Text] [Related]
7. Enhancing biosynthesis and secretion of premembrane and envelope proteins by the chimeric plasmid of dengue virus type 2 and Japanese encephalitis virus.
Chang GJ; Hunt AR; Holmes DA; Springfield T; Chiueh TS; Roehrig JT; Gubler DJ
Virology; 2003 Feb; 306(1):170-80. PubMed ID: 12620809
[TBL] [Abstract][Full Text] [Related]
8. Substitution of the precursor peptide prevents anti-prM antibody-mediated antibody-dependent enhancement of dengue virus infection.
Wang Y; Si LL; Guo XL; Cui GH; Fang DY; Zhou JM; Yan HJ; Jiang LF
Virus Res; 2017 Feb; 229():57-64. PubMed ID: 27939945
[TBL] [Abstract][Full Text] [Related]
9. Dengue and Zika Virus Domain III-Flagellin Fusion and Glycan-Masking E Antigen for Prime-Boost Immunization.
Lin HH; Yang SP; Tsai MJ; Lin GC; Wu HC; Wu SC
Theranostics; 2019; 9(16):4811-4826. PubMed ID: 31367259
[TBL] [Abstract][Full Text] [Related]
10. Identification of an epitope on the dengue virus membrane (M) protein defined by cross-protective monoclonal antibodies: design of an improved epitope sequence based on common determinants present in both envelope (E and M) proteins.
Falconar AK
Arch Virol; 1999; 144(12):2313-30. PubMed ID: 10664386
[TBL] [Abstract][Full Text] [Related]
11. Serotype-specific anti-Dengue virus NS1 mouse antibodies cross-react with prM and are potentially involved in virus production.
Masrinoul P; Omokoko MD; Pambudi S; Ikuta K; Kurosu T
Viral Immunol; 2013 Aug; 26(4):250-8. PubMed ID: 23941673
[TBL] [Abstract][Full Text] [Related]
12. Identification and characterization of a linearized B-cell epitope on the pr protein of dengue virus.
Song KY; Zhao H; Li SH; Li XF; Deng YQ; Wang HJ; Ye Q; Zhu SY; Jiang ZY; Zhang FC; Qin ED; Qin CF
J Gen Virol; 2013 Jul; 94(Pt 7):1510-1516. PubMed ID: 23559476
[TBL] [Abstract][Full Text] [Related]
13. Dengue Virus prM-Specific Human Monoclonal Antibodies with Virus Replication-Enhancing Properties Recognize a Single Immunodominant Antigenic Site.
Smith SA; Nivarthi UK; de Alwis R; Kose N; Sapparapu G; Bombardi R; Kahle KM; Pfaff JM; Lieberman S; Doranz BJ; de Silva AM; Crowe JE
J Virol; 2016 Jan; 90(2):780-9. PubMed ID: 26512092
[TBL] [Abstract][Full Text] [Related]
14. A tetravalent virus-like particle vaccine designed to display domain III of dengue envelope proteins induces multi-serotype neutralizing antibodies in mice and macaques which confer protection against antibody dependent enhancement in AG129 mice.
Ramasamy V; Arora U; Shukla R; Poddar A; Shanmugam RK; White LJ; Mattocks MM; Raut R; Perween A; Tyagi P; de Silva AM; Bhaumik SK; Kaja MK; Villinger F; Ahmed R; Johnston RE; Swaminathan S; Khanna N
PLoS Negl Trop Dis; 2018 Jan; 12(1):e0006191. PubMed ID: 29309412
[TBL] [Abstract][Full Text] [Related]
15. Preliminary evaluation of DNA vaccine candidates encoding dengue-2 prM/E and NS1: their immunity and protective efficacy in mice.
Lu H; Xu XF; Gao N; Fan DY; Wang J; An J
Mol Immunol; 2013 Jun; 54(2):109-14. PubMed ID: 23270684
[TBL] [Abstract][Full Text] [Related]
16. prM-reactive antibodies reveal a role for partially mature virions in dengue virus pathogenesis.
Dowd KA; Sirohi D; Speer SD; VanBlargan LA; Chen RE; Mukherjee S; Whitener BM; Govero J; Aleshnick M; Larman B; Sukupolvi-Petty S; Sevvana M; Miller AS; Klose T; Zheng A; Koenig S; Kielian M; Kuhn RJ; Diamond MS; Pierson TC
Proc Natl Acad Sci U S A; 2023 Jan; 120(3):e2218899120. PubMed ID: 36638211
[TBL] [Abstract][Full Text] [Related]
17. The stem region of premembrane protein plays an important role in the virus surface protein rearrangement during dengue maturation.
Zhang Q; Hunke C; Yau YH; Seow V; Lee S; Tanner LB; Guan XL; Wenk MR; Fibriansah G; Chew PL; Kukkaro P; Biukovic G; Shi PY; Shochat SG; Grüber G; Lok SM
J Biol Chem; 2012 Nov; 287(48):40525-34. PubMed ID: 23035113
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of chimeric DNA vaccines consisting of premembrane and envelope genes of Japanese encephalitis and dengue viruses as a strategy for reducing induction of dengue virus infection-enhancing antibody response.
Sjatha F; Kuwahara M; Sudiro TM; Kameoka M; Konishi E
Microbiol Immunol; 2014 Feb; 58(2):126-34. PubMed ID: 24372832
[TBL] [Abstract][Full Text] [Related]
19. Identification of human neutralizing antibodies that bind to complex epitopes on dengue virions.
de Alwis R; Smith SA; Olivarez NP; Messer WB; Huynh JP; Wahala WM; White LJ; Diamond MS; Baric RS; Crowe JE; de Silva AM
Proc Natl Acad Sci U S A; 2012 May; 109(19):7439-44. PubMed ID: 22499787
[TBL] [Abstract][Full Text] [Related]
20. Virus-like particles derived from Pichia pastoris-expressed dengue virus type 1 glycoprotein elicit homotypic virus-neutralizing envelope domain III-directed antibodies.
Poddar A; Ramasamy V; Shukla R; Rajpoot RK; Arora U; Jain SK; Swaminathan S; Khanna N
BMC Biotechnol; 2016 Jun; 16(1):50. PubMed ID: 27301568
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
